propedeutics-spb.ru


SERA PROGNOSTICS STOCK

Analyst's Opinion · Consensus Rating. Sera Prognostics has received a consensus rating of Moderate Buy. · Price Target Upside/Downside. According to analysts'. Sera Prognostics Inc. · Industry Biotechnology · Sector Health Care/Life Sciences · Fiscal Year-end 12/ · Revenue $K · Net Income -$M · Sales Growth. Sera today announced the pricing of its initial public offering of shares of its common stock at a price to the public of $ per share. With an oversight board recommending Sera Prognostics halt its clinical study for efficacy, SERA stock soared on the positive implications. Free Report. Sera Prognostics' vision as The Pregnancy Company is to be a leader in health diagnostics to improve the lives of women and babies through prenatal care.

Sera Prognostics Inc Class A SERA ; Valuation · Price/Earnings (Normalized). — ; Financial Strength · Quick Ratio. ; Profitability · Return on Assets (Normalized). Sera Prognostics, Inc. (SERA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with. Sera Prognostics, Inc. Class A · Price Momentum. SERA is trading near the top of its week range and above its day simple moving average. · Price change. Sera Prognostics Inc. (NASDAQ: SERA) will report Q4 and full year financial results on March 20, The company focuses on pregnancy biomarker. On Monday 03/04/ the closing price of the Sera Prognostics Inc Registered Shs -A- share was $ on NAS. Compared to the opening price on Monday 03/04/ View the SERA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sera Prognostics Inc. Historical Stock Price. Select the date below to view the historical closing price for that particular day. The closing price is not indicative of future price. SERA Stock Overview Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving. Amid another soft session on Wall Street, Sera Prognostics (NASDAQ: SERA) — a specialist in the field of maternal and neonatal health — shook up the market. Stock analysis for Sera Prognostics Inc (SERA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Sera Prognostics Inc (SERA) Stock Performance ; Sera Prognostics Inc (SERA). , ; S&P BSE Sensex. , ; S&P Small-Cap · ,

Get real-time updates on Sera Prognostics, Inc. Class A Common Stock (SERA) stock quotes, trades, and more. Make informed investments with Nasdaq. SERA | Complete Sera Prognostics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Complete Sera Prognostics Inc. stock information by Barron's. View real-time SERA stock price and news, along with industry-best analysis. According to one analyst, the rating for SERA stock is "Hold" and the month stock price forecast is $ Price Target. Discover real-time Sera Prognostics, Inc. Class A Common Stock (SERA) stock prices, quotes, historical data, news, and Insights for informed trading and. Last quarter Sera Prognostics - Class A reported $42, in Revenue and -$ earnings per share. This fell short of revenue expectation by $, and. Sera Prognostics Inc. SERA (U.S.: Nasdaq). AT CLOSE PM EDT 03/08/ $USD; %. Volume46, AFTER HOURS PM EDT 03/08/ Sera Prognostics Inc (SERA) PT Raised to $ at CitiCiti analyst Patrick Donnelly raised the price target on Sera Prognostics Inc (NASDAQ: SERA) to $ . Sera Prognostics (SERA) has a Smart Score of 6 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund.

Amid another soft session on Wall Street, Sera Prognostics (NASDAQ: SERA) — a specialist in the field of maternal and neonatal health — shook up the market. Get Sera Prognostics Inc (SERA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker. Volume, M. Market Value, $M. Shares Outstanding, M. EPS (TTM), -$ P/E Ratio (TTM), N/A. Dividend Yield, N/A. Latest Dividend, N/A. Sera Prognostics Inc. historical stock charts and prices, analyst ratings, financials, and today's real-time SERA stock price.

In depth view into SERA (Sera Prognostics) stock including the latest price, news, dividend history, earnings information and financials. SERA - Sera Prognostics, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGM) ; Owners. Institutional Owners Retail Ownership Net. Sera Prognostics, Inc. stock is up % since 30 days ago. The next earnings date is Mar 20, The company has had above-average volume in the last Sera Prognostics (SERA) reported Q3 earnings per share (EPS) of -$, beating estimates of -$ by %. In the same quarter last year, Sera. With an oversight board recommending Sera Prognostics halt its clinical study for efficacy, SERA stock soared on the positive implications. Free Report. Sera Prognostics Inc ; Index, -, P/E ; Market Cap, M, Forward P/E ; Income, M, PEG ; Sales, M, P/S ; Book/sh, , P/B. Sera Prognostics Inc. (NASDAQ: SERA) will report Q4 and full year financial results on March 20, The company focuses on pregnancy biomarker. Sera Prognostics Inc Performance ; Diluted EPS (TTM), ; Revenue Growth YOY, % ; Earnings Growth YOY, 0% ; Profit margin, 0%.

tesla stock pre market | exxon mobil argentina

is chargepoint a good stock to buy price of slv borgwarner stock forecast didi stock forecast skybridge crypto etf docusign stock price today

Copyright 2019-2024 Privice Policy Contacts SiteMap RSS